ETHAMYCIN LIQ 500MG DIN 00257893
Status: Cancelled Post Market
Holder: PFIZER CANADA INC ANIMAL HEALTH GROUP
Health Canada record
| Active ingredient(s) | DIHYDROSTREPTOMYCIN (DIHYDROSTREPTOMYCIN SULFATE) 500 MG |
|---|---|
| Dosage form | Liquid |
| Route | Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1961 |
| Current status date | 30-Jul-2012 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Request a quote for ETHAMYCIN LIQ 500MG